EyePoint Pharmaceuticals gets grant for treatment of ocular conditions using multi-specific compounds

17h ago, source: Pharmaceutical Technology

Discover the groundbreaking patent by EyePoint Pharmaceuticals for treating ocular conditions with multi-specific compounds targeting phosphatase and receptor tyrosine kinase agonists. Treat diabetic ...

EyePoint Pharmaceuticals Inc EYPT

3d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

Critical Insights From EyePoint Pharmaceuticals Analyst Ratings: What You Need To Know

1mon ago, source: Benzinga.com

Stay informed and make well-informed decisions with our Ratings Table. EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products ...

Buy Recommendation: EyePoint Pharmaceuticals’ Promising Outlook with EYP-1901 for Diabetic Retinopathy and AMD

5d ago, source:

Analyst Graig Suvannavejh of Mizuho Securities reiterated a Buy rating on EyePoint Pharmaceuticals (EYPT – Research Report), retaining ...

EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Q4 2023 Earnings Call Transcript

1mon ago, source: Insider Monkey

Operator: Thank you. One moment for our next question. Our next question comes from the line of Yi Chen from H.C. Wainwright. Your line is open. Yi Chen: Thank you for taking my question. Can you ...

EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

1mon ago, source: Stockhouse

WATERTOWN, Mass., March 18, 2024 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing therapeutics to help improve the lives of ...

EyePoint Pharmaceuticals Announces Appointment of Ramiro Ribeiro, M.D., Ph.D. as Chief Medical Officer

1mon ago, source: ADVFN

EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing therapeutics to help improve the lives of patients with serious retinal diseases, today ...

EyePoint Pharmaceuticals Inc EYPT

7d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

EyePoint Pharmaceuticals, Inc. (EYPT)

1mon ago, source: Yahoo Finance

Overall score is calculated based on proprietary scores based on sector averages in key company indicators: fair value, dividends, innovation, hiring, and insider sentiment. Note: if you don't see ...

EyePoint Pharmaceuticals Inc.

28d ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...